BACHEM N revenue breakdown overview

BACHEM N revenue for the last year amounted to 577.32 M CHF, the most of which — 309.03 M CHF — came from its highest performing source at the moment, Commercial Active Pharmaceutical Ingredients, the year earlier bringing 298.79 M CHF. The greatest contribution to the revenue figure was made by Europe / Asia — last year it brought BACHEM N 362.15 M CHF, and the year before that — 316.44 M CHF.